Pfizer Inc (PFE) Stock Price, Quote & News

Company Profile

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. It operates in three segments: Biopharma, PC1, and Pfizer Ignite. The company offers internal medicine products, including cardiovascular metabolic diseases products under the Eliquis brand; migraine products under the Nurtec ODT/Vydura and Zavzpret brand; vaccines under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands;...

Industry: Drug Manufacturers - General

Sector: Healthcare

Phone: 212 733 2323

Website: www.pfizer.com

Address:

66 Hudson Boulevard East, New York, United States

Loudermilk64 Aug. 25 at 4:45 PM

$PFE Going higher.

0 · Reply

RocroBio Aug. 25 at 4:43 PM

$PFE

0 · Reply

RocroBio Aug. 25 at 4:43 PM

$PFE

0 · Reply

JBS_84 Aug. 25 at 4:39 PM

$PFE completely depends on mrna. Compare our chart to mrna. They are trading exactly the same. That means hype. That means very risky.

0 · Reply

reyofhope Aug. 25 at 4:30 PM

$PFE live look bourla doing the Greek dance.

0 · Reply

Jtlo Aug. 25 at 3:58 PM

$PFE send it bourla

0 · Reply

PFElinepfrenzy1990 Aug. 25 at 3:28 PM

$PFE - Bruv, bit odd, innit?

3 · Reply

TheUnmaker Aug. 25 at 3:15 PM

$TNXP https://www.stocktitan.net/news/TNXP/tonix-pharmaceuticals-announces-major-managed-medicare-payer-2zlnl3uf4paw.html $PFE $SLS $IOVA

0 · Reply

TheUnmaker Aug. 25 at 3:13 PM

$TNXP $PFE $SLS $IOVA https://www.stocktitan.net/news/TNXP/tonix-pharmaceuticals-announces-major-managed-medicare-payer-2zlnl3uf4paw.html

0 · Reply

zustrelaax Aug. 25 at 3:10 PM

$PFE bring the sling shot missed last week on the $MRNA day

0 · Reply

Pfizer Stock (PFE) Is a Buy despite Declining Revenue

2026-08-19T14:35:12.000Z - 6 days ago

Pfizer (PFE) Stock Rallies 4% Thanks to Merck (MRK) and Moderna (MRNA)’s Cancer Trial Update

BNTX MRK MRNA

2026-08-16T13:55:21.000Z - 9 days ago

Pfizer, Valneva announce EMA validation for PF-07307405 MAA

VALN

2026-08-14T18:45:04.000Z - 10 days ago

Pfizer (PFE) CEO Buys $1 Million of Company Stock

Aug 14, 2026, 1:45 PM EDT - 10 days ago

Pfizer CEO Caps Post-Earnings Insider Buying Spree With $1 Million Stock Purchase

Aug 14, 2026, 11:46 AM EDT - 11 days ago

Closed Pfizer biopharma facility in Everett gets a new lease on life

Aug 14, 2026, 11:11 AM EDT - 11 days ago

Pfizer is paying $44 million to settle a Chantix lawsuit. See who could get money

2026-08-14T13:47:35.000Z - 11 days ago

Valneva Stock (VALN) Soars Over 20% On Lyme Disease Vaccine Hopes

VALN

Aug 14, 2026, 1:00 AM EDT - 11 days ago

Pfizer and Valneva's Lyme Disease Vaccine Candidate Marketing Authorization Application Validated by European Medicines Agency

VALN

2026-08-07T11:40:49.000Z - 18 days ago

Pfizer price target lowered to $31 from $35 at Guggenheim

Aug 4, 2026, 10:00 AM EDT - 21 days ago

Pfizer Earnings Call Transcript: Q2 2026

Aug 4, 2026, 10:00 AM EDT - 21 days ago

Pfizer Earnings release: Q2 2026

Aug 4, 2026, 10:00 AM EDT - 21 days ago

Pfizer Slides: Q2 2026

Aug 4, 2026, 10:00 AM EDT - 21 days ago

Pfizer Quarterly report: Q2 2026

Aug 4, 2026, 7:24 AM EDT - 21 days ago

Pfizer Post Loss on Higher Revenue

Aug 4, 2026, 7:13 AM EDT - 21 days ago

Pfizer tops quarterly estimates, hikes low end of revenue guidance on strength of non-Covid products

Aug 4, 2026, 7:12 AM EDT - 21 days ago

Why Pfizer Stock and This Covid Vaccine Partner Are Falling on Earnings

BNTX

Aug 4, 2026, 6:52 AM EDT - 21 days ago

Pfizer beats quarterly profit estimates on strong demand for blood thinner Eliquis

Aug 4, 2026, 6:45 AM EDT - 21 days ago

Pfizer Reports Second-Quarter Results And Raises Midpoint of 2026 Revenue Guidance

Jul 30, 2026, 7:48 AM EDT - 26 days ago

Pfizer's oral drug restores skin pigmentation in late-stage vitiligo trials

Jul 30, 2026, 6:45 AM EDT - 26 days ago

Pfizer Announces Positive Topline Phase 3 Results for LITFULO in Patients with Nonsegmental Vitiligo

Jul 29, 2026, 4:30 PM EDT - 26 days ago

European Commission Authorizes Pfizer and BioNTech XFG-adapted COVID-19 Vaccine in the European Union

BNTX

Jul 22, 2026, 4:48 PM EDT - 4 weeks ago

Pfizer's prostate cancer drug combination gets US FDA priority review

Jul 22, 2026, 4:30 PM EDT - 4 weeks ago

FDA Grants Priority Review for Pfizer's TALZENNA Plus XTANDI for the Treatment of Metastatic Prostate Cancer

Jul 21, 2026, 7:10 PM EDT - 4 weeks ago

Trump says generic drugs to face no US tariffs for 2 years before rates of 100% and 200% later

LLY

Jul 16, 2026, 1:39 PM EDT - 5 weeks ago

Pfizer suspends sales of Premarin vaginal cream in India, citing supply challenges

Jul 10, 2026, 11:23 AM EDT - 6 weeks ago

U.S. FDA Approves PADCEV® plus Keytruda® as Neoadjuvant and Adjuvant Treatment for Muscle-Invasive Bladder Cancer Regardless of Cisplatin Eligibility

Jul 6, 2026, 10:00 AM EDT - 7 weeks ago

Options Corner: PFE Downgrade, Stock Slides Near 52-Week Low

Jun 29, 2026, 4:43 PM EDT - 2 months ago

Value stocks beat growth when inflation is high. Here are 13 stocks top newsletters are betting on now.

ABT ADM APD BAC CMCSA CVS DIS

Jun 29, 2026, 1:20 AM EDT - 2 months ago

Pfizer, Innovent GLP-1 drugs pass China insurance preliminary review

Jun 24, 2026, 3:52 PM EDT - 2 months ago

Pfizer Declares Third-Quarter 2026 Dividend

Jun 24, 2026, 2:10 PM EDT - 2 months ago

FDA Approves Pfizer's IBRANCE Regimen for HR+, HER2+ Metastatic Breast Cancer Frontline Maintenance

Jun 24, 2026, 10:51 AM EDT - 2 months ago

Pfizer dismissed from US states' drug price-fixing lawsuit

Jun 23, 2026, 12:10 PM EDT - 2 months ago

China outpacing Europe in drug innovation and development, Pfizer executive says

Jun 23, 2026, 10:00 AM EDT - 2 months ago

Pfizer Invites Public to View and Listen to Webcast of August 4 Conference Call with Analysts

Jun 22, 2026, 4:43 PM EDT - 2 months ago

Pfizer's experimental drug misses main goal of lung cancer trial

Jun 22, 2026, 4:30 PM EDT - 2 months ago

Pfizer Announces Topline Phase 3 Results for Sigvotatug Vedotin in Previously Treated Metastatic Non-Squamous Non-Small Cell Lung Cancer

Jun 22, 2026, 2:32 PM EDT - 2 months ago

Wall Street loves growth stocks — but these 10 ‘losers' are primed to win

ACHR AGCO COF DHI DVN EOG TSN

Jun 18, 2026, 6:52 AM EDT - 2 months ago

Pfizer CFO Dave Denton to step down, leave company in August

Jun 18, 2026, 6:45 AM EDT - 2 months ago

Pfizer Announces Chief Financial Officer Transition

Jun 10, 2026, 7:56 AM EDT - 2 months ago

Pfizer CEO warns German investment at risk over drug pricing policies

Jun 9, 2026, 2:07 PM EDT - 2 months ago

Want to Avoid the Whipsawing Tech Stocks? Dollar General and 7 Others to Buy.

DG ALGN BBY BIIB CVS VZ

Jun 9, 2026, 9:20 AM EDT - 2 months ago

Trouble Ahead For GLP-1 Drugs As Health Plans Stop Paying

AMGN JNJ LLY MRK NVO

Jun 9, 2026, 3:20 AM EDT - 2 months ago

The space race is coming for pharma: Why drug development is heading to lower Earth orbit

BMY LLY MRK RDW UTHR XBI

Jun 8, 2026, 8:00 AM EDT - 2 months ago

Pfizer Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026

Jun 8, 2026, 6:49 AM EDT - 2 months ago

US FDA approves Pfizer's bleeding disorder drug for children

Jun 8, 2026, 6:45 AM EDT - 2 months ago

U.S. FDA Approves Pfizer's HYMPAVZI for the Treatment of Two Additional Hemophilia A or B Patient Populations with Significant Medical Need

Jun 6, 2026, 11:00 AM EDT - 2 months ago

Pfizer Transcript: Study update

Jun 6, 2026, 11:00 AM EDT - 2 months ago

Pfizer Slides: Study update

Jun 6, 2026, 11:00 AM EDT - 2 months ago

Pfizer Press release: Study update

Jun 6, 2026, 9:06 AM EDT - 2 months ago

Pfizer's monthly obesity shot has side-effect profile similar to Wegovy in midstage trial

Jun 6, 2026, 9:00 AM EDT - 2 months ago

Robust Phase 2b Efficacy and Favorable Tolerability Support Monthly Dosing for Pfizer's GLP-1 RA Berobenatide

Jun 4, 2026, 10:00 AM EDT - 2 months ago

Chai Discovery Announces License Agreement with Pfizer to Accelerate Drug Discovery with AI

Jun 4, 2026, 6:40 AM EDT - 2 months ago

Why Pfizer And Eli Lilly Are Betting On This $1.3 Billion AI Drug Discovery Startup

LLY

Jun 3, 2026, 2:00 PM EDT - 2 months ago

Pfizer Transcript: Jefferies Global Healthcare Conference 2026

Jun 1, 2026, 10:00 AM EDT - 3 months ago

Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference

May 31, 2026, 8:00 AM EDT - 3 months ago

Pfizer's BRAFTOVI Regimen Nearly Doubles Median Progression-Free Survival in Metastatic Colorectal Cancer

May 30, 2026, 8:00 AM EDT - 3 months ago

TALZENNA Plus XTANDI Improves Radiographic Progression-Free Survival by More Than 50% in Metastatic Prostate Cancer

May 29, 2026, 8:00 AM EDT - 3 months ago

Seven-Year Analysis from Pfizer's LORBRENA CROWN Trial Shows Longest Progression-Free Survival Reported to Date in Advanced Non-Small Cell Lung Cancer

May 28, 2026, 11:10 PM EDT - 3 months ago

Innovent Biologics shares rise 10% after pact with Pfizer of up to $10.5 billion

May 28, 2026, 7:19 PM EDT - 3 months ago

China's Innovent Biologics, Pfizer strike up to $10.5 billion cancer drug deal

May 28, 2026, 7:00 PM EDT - 3 months ago

Innovent Biologics and Pfizer Enter Global Strategic Collaboration to Accelerate Development of Innovative Oncology Medicines

May 28, 2026, 7:00 PM EDT - 3 months ago

Pfizer and Innovent Biologics Enter Global Strategic Collaboration to Accelerate Development of Innovative Oncology Medicines

May 27, 2026, 10:00 AM EDT - 3 months ago

Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference

Loudermilk64 Aug. 25 at 4:45 PM

$PFE Going higher.

0 · Reply

RocroBio Aug. 25 at 4:43 PM

$PFE

0 · Reply

RocroBio Aug. 25 at 4:43 PM

$PFE

0 · Reply

JBS_84 Aug. 25 at 4:39 PM

$PFE completely depends on mrna. Compare our chart to mrna. They are trading exactly the same. That means hype. That means very risky.

0 · Reply

reyofhope Aug. 25 at 4:30 PM

$PFE live look bourla doing the Greek dance.

0 · Reply

Jtlo Aug. 25 at 3:58 PM

$PFE send it bourla

0 · Reply

PFElinepfrenzy1990 Aug. 25 at 3:28 PM

$PFE - Bruv, bit odd, innit?

3 · Reply

TheUnmaker Aug. 25 at 3:15 PM

$TNXP https://www.stocktitan.net/news/TNXP/tonix-pharmaceuticals-announces-major-managed-medicare-payer-2zlnl3uf4paw.html $PFE $SLS $IOVA

0 · Reply

TheUnmaker Aug. 25 at 3:13 PM

$TNXP $PFE $SLS $IOVA https://www.stocktitan.net/news/TNXP/tonix-pharmaceuticals-announces-major-managed-medicare-payer-2zlnl3uf4paw.html

0 · Reply

zustrelaax Aug. 25 at 3:10 PM

$PFE bring the sling shot missed last week on the $MRNA day

0 · Reply

Fire_Truck Aug. 25 at 3:07 PM

$TNXP $PFE $SLS $IOVA Is Tonmya a placebo drug. 🤔

2 · Reply

TheUnmaker Aug. 25 at 3:02 PM

$TNXP I was happy to shift some of my $PFE profits into this last week after months of accumulating Pfizer under $25. We are nearing out break out moment.

0 · Reply

NorthOfSouth Aug. 25 at 3:00 PM

$PFE RSI running a bit hot to take us to 30 today...prove me wrong

2 · Reply

doubleuptwice Aug. 25 at 2:59 PM

$PFE getting juicy 🍋

0 · Reply

INEEDMONEY87 Aug. 25 at 2:45 PM

$PFE is this real?

1 · Reply

Loudermilk64 Aug. 25 at 2:43 PM

$PFE over 30 next then?

0 · Reply

TheUnmaker Aug. 25 at 2:28 PM

$TNXP Insiders been buying, tutes have been buying. Coverage expanding to 144M patients and growing, first FDA approved fibromyalgia drug in 15 years, RX weekly scripts have been growing. Why aren't you buying? $PFE $SLS $IOVA

3 · Reply

AnalyistKant Aug. 25 at 2:26 PM

$MRNA 👀 The $128 key support held, and Moderna is bouncing again. 📈 Barclays: PT raised $48 → $125 📈 Wolfe Research: upgraded Underperform → Peer Perform But the real catalyst remains: Moderna × Merck personalized cancer vaccine — Phase 3 Watch the levels: $145 reclaim → $155 breakout → $174–178 back in play. This isn’t just the COVID vaccine story anymore. The pipeline is evolving. $MRK $BNTX $PFE

0 · Reply

doubleuptwice Aug. 25 at 2:19 PM

$PFE springboard off 2816??

0 · Reply

Makingmillions192 Aug. 25 at 12:50 PM

$LEXX This industry is ripe for deals and acquisitions 🔥 Our time is coming ⏰ https://www.biopharmadive.com/news/roche-lean-mass-preservation-hanmi-obesity-deal/828579/ $RHHBY $LLY $NVO $PFE

0 · Reply

Reversal_Levels Aug. 25 at 9:22 AM

Trade update. PFE is on pP signal (partial profits). We will use it to close this trade early at today's Open. Longer term investors can still hold (or sell half), but we try to show some different strategies. We can always pick $PFE back up if it comes down to test its RevL. In the chart we see how PFE is bumping into a double key price level, while PuLL and MoM look toppish. More: https://blog.reversallevels.com/2026/08/trading-journal-aug-25-2026.html (previous: https://x.com/lunatictrader1/status/2077710846394769855 )

0 · Reply

Etiqute Aug. 25 at 8:15 AM

$PFE Pfizer PFE -0.36% ▼ stock is a Buy despite declining revenue, in my view. Shares of the drugmaker have been modestly ahead of the S&P 500 (SPX) in 2026, helped by an upwardly revised revenue guidance as well as a cheap valuation. With a 6.13% dividend yield and a 2026 non-GAAP P/E multiple of 9.43x, PFE stock is indeed one of the most compelling value opportunities in the large-cap healthcare space.

0 · Reply

Market Cap	159.99B
Revenue (ttm)	62.58B
Net Income (ttm)	7.77B
EPS (ttm)	N/A
PE Ratio	9.11
Forward PE	9.33
Profit Margin	12.42%
Debt to Equity Ratio	0.74

Volume	12,152,234
Avg Vol	44,625,605
Day's Range	N/A - N/A
Shares Out	5.70B
Stochastic %K	84%
Beta	0.34
Analysts	Sell
Price Target	$28.60